Clearmind Medicine Advances Recruitment for CMND-100 Trial's Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline Results
NASDAQ:CMND|Bullish|11 Mar 2026 · 3 days ago
Read More →Want to know each day's companies with the most bullish news?
1 article · filtered by CMND